Antoine David, Chuich Taylor, Mylvaganam Ruben, Malaisrie Chris, Freed Benjamin, Cuttica Michael, Schimmel Daniel
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, USA.
Department of Pharmacy, NewYork-Presbyterian, New York, USA.
Pulm Circ. 2020 Sep 28;10(3):2045894020953724. doi: 10.1177/2045894020953724. eCollection 2020 Jul-Sep.
Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic thrombolysis versus anticoagulation alone and their effect on left ventricular outflow tract velocity time integral. This was a retrospective cohort study of subjects ≥18 years of age with a diagnosis of submassive or massive pulmonary embolism. The primary outcome was the percent change in left ventricular outflow tract velocity time integral between pre- and post-treatment echocardiograms. Ultrasound-accelerated thrombolysis compared to anticoagulation had a greater improvement in left ventricular outflow tract velocity time integral, measured by percent change. No significant change was noted between the ultrasound-accelerated thrombolysis and systemic thrombolysis nor systemic thrombolysis and anticoagulation groups. Pulmonary artery systolic pressure only showed a significant reduction in the ultrasound-accelerated thrombolysis versus anticoagulation group. The percent change of right ventricular to left ventricular ratios was improved when systemic thrombolysis was compared to both ultrasound-accelerated thrombolysis and anticoagulation. In this retrospective study of submassive or massive pulmonary embolisms, left ventricular outflow tract velocity time integral demonstrated greater improvement in patients treated with ultrasound-accelerated thrombolysis as compared to anticoagulation alone, a finding not seen with systemic thrombolysis. While this improvement in left ventricular outflow tract velocity time integral parallels the trend seen in mortality outcomes across the three groups, it only correlates with changes seen in pulmonary artery systolic pressure, not in other markers of echocardiographic right ventricular dysfunction (tricuspid annular plane systolic excursion and right ventricular to left ventricular ratios). Changes in left ventricular outflow tract velocity time integral, rather than echocardiographic markers of right ventricular dysfunction, may be considered a more useful prognostic marker of both dysfunction and improvement after reperfusion therapy.
肺栓塞与高死亡率和高发病率相关。了解当前干预措施的直接比较以区分有利结果和并发症很重要。本研究的目的是比较超声加速溶栓与全身溶栓以及单独抗凝治疗及其对左心室流出道速度时间积分的影响。这是一项对年龄≥18岁、诊断为次大面积或大面积肺栓塞的受试者进行的回顾性队列研究。主要结局是治疗前后超声心动图检查中左心室流出道速度时间积分的变化百分比。通过变化百分比测量,与抗凝治疗相比,超声加速溶栓使左心室流出道速度时间积分有更大改善。超声加速溶栓组与全身溶栓组之间以及全身溶栓组与抗凝组之间均未观察到显著变化。仅在超声加速溶栓组与抗凝组之间,肺动脉收缩压显示出显著降低。与超声加速溶栓组和抗凝组相比,全身溶栓时右心室与左心室比率的变化百分比有所改善。在这项关于次大面积或大面积肺栓塞的回顾性研究中,与单独抗凝治疗相比,接受超声加速溶栓治疗的患者左心室流出道速度时间积分有更大改善,全身溶栓未出现此结果。虽然左心室流出道速度时间积分的这种改善与三组死亡率结局的趋势相似,但它仅与肺动脉收缩压的变化相关,与超声心动图显示的右心室功能障碍的其他指标(三尖瓣环平面收缩期位移和右心室与左心室比率)无关。左心室流出道速度时间积分的变化,而非右心室功能障碍的超声心动图指标,可能被认为是再灌注治疗后功能障碍和改善的更有用的预后指标。